GlySens Incorporated
PrivateLast Round
VC Round
Jun 12, 2020
Total Funding Raised
$32.1M
Company Overview
GlySens Incorporated operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a VC Round in June 2020.
GlySens Incorporated is a biotechnology company that develops implantable continuous glucose monitoring systems for diabetes management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sensors, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlySens Incorporated Comparables
Compare GlySens Incorporated with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlucoTrack Inc | 82% | |
| Senseonics Holdings, Inc. | 81% | |
| Indigo Diabetes N.V. | 77% |
For institutional investors. Book with your work email.
GlySens Incorporated Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 12, 2020 | ||||
| Series D | Jan 5, 2016 | ||||
| Series C | Jan 5, 2015 | ||||
| VC Round | Sep 14, 2012 | ||||
| Grant | Jan 1, 2005 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GlySens Incorporated Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| McNair Interests | VC Round |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Windham Capital Partners | Series D |
| Fayez Sarofim & Co. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2012
Led by West Health, an Impact Investor.
For institutional investors. Book with your work email.
GlySens Incorporated Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GlySens Incorporated's valuation, stock price, and market status.
Is GlySens Incorporated a public or private company?
GlySens Incorporated is a private company.
What is the current stock price of GlySens Incorporated?
GlySens Incorporated is a private company, so its shares have no public market price. Caplight tracks GlySens Incorporated's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GlySens Incorporated worth (valuation)?
Valuation information for GlySens Incorporated is not publicly available.
Can I buy GlySens Incorporated stock?
GlySens Incorporated shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GlySens Incorporated's last funding round?
GlySens Incorporated's most recent funding round was VC Round on June 12, 2020.
Who are the main investors in GlySens Incorporated?
Key investors in GlySens Incorporated include McNair Interests, National Institute of Diabetes and Digestive and Kidney Diseases, Fayez Sarofim & Co..
Will GlySens Incorporated IPO soon?
No public IPO plans have been announced for GlySens Incorporated.
How can I track GlySens Incorporated secondary market activity?
Caplight tracks bids, offers, and trades in GlySens Incorporated's shares on secondary markets.